MIM received honoraria for speaking at meetings from AstraZeneca, Novo Nordisk, Bruno Farmaceutici, Mundipharma, and Sanofi
A significant number of patients experience nausea and gastrointestinal discomfort when starting tirzepatide
Discovery Date: 1973 GHK-Cu is not approved for human consumption, medical use, or therapeutic application
While generally safe, we advise consulting with your healthcare professional, especially if you have pre-existing medical conditions or are pregnant/nursing
While you can also dispose of those in sharps containers, they are a bit bulkier and take up more space
Supplements and Treatments Evidence-based interventions can support hair growth during Ozempic therapy